{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:43:36Z","timestamp":1790081016162,"version":"4.0.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2019.01304","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T04:51:02Z","timestamp":1575521462000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Failures in Protein Clearance Partly Underlie Late Onset Neurodegenerative Diseases and Link Pathology to Genetic Risk"],"prefix":"10.3389","volume":"13","author":[{"given":"John","family":"Hardy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,12,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/hmg\/8.4.711","article-title":"Association of an extended haplotype in the tau gene with progressive supranuclear palsy.","volume":"8","author":"Baker","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nrd.2018.109","article-title":"Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.","volume":"17","author":"Boland","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2013.00122","article-title":"Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease.","volume":"4","author":"Chesser","year":"2013","journal-title":"Front. Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s10654-017-0320-5","article-title":"Trends in the incidence of dementia: design and methods in the Alzheimer Cohorts consortium.","volume":"32","author":"Chibnik","year":"2017","journal-title":"Eur. J. Epidemiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1073\/pnas.1516604113","article-title":"A transcriptional signature of Alzheimer\u2019s disease is associated with a metastable subproteome at risk for aggregation.","volume":"113","author":"Ciryam","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/jnen\/64.2.104","article-title":"The role of caspase cleavage of tau in Alzheimer disease neuropathology.","volume":"64","author":"Cotman","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/jamaneurol.2013.172","article-title":"Parkin disease: a clinicopathologic entity?","volume":"70","author":"Doherty","year":"2103","journal-title":"JAMA Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1093\/hmg\/10.17.1847","article-title":"Alpha-synuclein gene haplotypes are associated with Parkinson\u2019s disease.","volume":"10","author":"Farrer","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600947","article-title":"A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer\u2019s disease.","volume":"2","author":"Freer","year":"2016","journal-title":"Sci. Adv."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2010.09.008","article-title":"Cleavage of Tau by calpain in Alzheimer\u2019s disease: the quest for the toxic 17 kD fragment.","volume":"32","author":"Garg","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"B11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics.","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ng.859","article-title":"Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.","volume":"43","author":"H\u00f6glinger","year":"2011","journal-title":"Nat. Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1126\/science.282.5395.1914","article-title":"Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.","volume":"282","author":"Hong","year":"1998","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/nn.4587","article-title":"A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer\u2019s disease.","volume":"20","author":"Huang","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B15","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","article-title":"Association of missense and 5\u2019-splice-site mutations in tau with the inherited dementia FTDP-17.","volume":"393","author":"Hutton","year":"1998","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/ana.25308","article-title":"Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype.","volume":"84","author":"Jabbari","year":"2018","journal-title":"Ann. Neurol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013950","article-title":"Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer\u2019s disease.","volume":"5","author":"Jones","year":"2010","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1042\/EBC20170023","article-title":"Autophagy impairment in Parkinson\u2019s disease.","volume":"61","author":"Karabiyik","year":"2017","journal-title":"Essays Biochem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/ana.24188","article-title":"A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease.","volume":"76","author":"Karran","year":"2014","journal-title":"Ann. Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies.","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ceb.2017.03.013","article-title":"PINK1 and parkin: emerging themes in mitochondrial homeostasis.","volume":"45","author":"McWilliams","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nm.4011","article-title":"Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling.","volume":"22","author":"Myeku","year":"2016","journal-title":"Nat. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"34414","DOI":"10.1074\/jbc.M113.508812","article-title":"Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1. ABCA7, and ABCA4 and disease-causing mutants.","volume":"288","author":"Quazi","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B24","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/brain\/awx285","article-title":"International Parkinson\u2019s Disease genomics consortium (IPDGC), Heutink P, Shulman JM. excessive burden of lysosomal storage disorder gene variants in Parkinson\u2019s disease.","volume":"140","author":"Robak","year":"2017","journal-title":"Brain"},{"key":"B25","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3233\/JAD-2010-100441","article-title":"Frontotemporal dementia phenotype associated with MAPT gene duplication.","volume":"21","author":"Rovelet-Lecrux","year":"2010","journal-title":"J. Alzheimers. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ng1718","article-title":"APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy.","volume":"38","author":"Rovelet-Lecrux","year":"2006","journal-title":"Nat. Genet."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1101\/437657","article-title":"Genetic variability in response to A\u03b2 deposition influences Alzheimer\u2019s risk.","author":"Salih","year":"2018","journal-title":"BioRxiv."},{"key":"B28","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease.","volume":"12","author":"Scheuner","year":"1996","journal-title":"Nat Med."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/science.1090278","article-title":"Alpha-synuclein locus triplication causes Parkinson\u2019s disease.","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"B30","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies.","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model.","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.01304\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T04:51:05Z","timestamp":1575521465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.01304\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,5]]},"references-count":31,"alternative-id":["10.3389\/fnins.2019.01304"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2019.01304","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,5]]},"article-number":"1304"}}